138 related articles for article (PubMed ID: 7765675)
1. Quality patents.
Sinclair K
Australas Biotechnol; 1994; 4(5):284. PubMed ID: 7765675
[TBL] [Abstract][Full Text] [Related]
2. Australia experiments with 'experimental use' exemption.
McBratney A; Nielsen K; McMillan F
Nat Biotechnol; 2004 Aug; 22(8):1023-5. PubMed ID: 15286651
[TBL] [Abstract][Full Text] [Related]
3. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
Abbot J
J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
[TBL] [Abstract][Full Text] [Related]
5. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
Lawson C
J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
[TBL] [Abstract][Full Text] [Related]
6. Toward an international standard of scientific inquiry.
Smith GP
Health Matrix Clevel; 1992; 2(2):167-91. PubMed ID: 10124878
[No Abstract] [Full Text] [Related]
7. Nontraditional publications and their effect on patentable inventions.
Garabedian TE
Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
[No Abstract] [Full Text] [Related]
8. Clarification of the Australian Patent Office's implementation of the Budapest Treaty.
Kurts A
Australas Biotechnol; 1994; 4(5):278-9. PubMed ID: 7765673
[No Abstract] [Full Text] [Related]
9. US courts narrow patent exemptions.
Fox JL
Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
[No Abstract] [Full Text] [Related]
10. Balancing innovation and access to healthcare through the patent system--an Australian perspective.
Nicol D
Community Genet; 2005; 8(4):228-34. PubMed ID: 16244477
[TBL] [Abstract][Full Text] [Related]
11. A guide to drug discovery. Protecting your inventions: the patent system.
Webber PM
Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385
[TBL] [Abstract][Full Text] [Related]
12. Errors in patent application sequence listings.
Jones R
Nat Biotechnol; 2003 Oct; 21(10):1239-40. PubMed ID: 14520406
[No Abstract] [Full Text] [Related]
13. Inventions in biotechnology and the assessment of obviousness.
Finney K
Australas Biotechnol; 1994; 4(5):280-3. PubMed ID: 7765674
[TBL] [Abstract][Full Text] [Related]
14. Charges fly in $1bn hormone patent battle.
Dalton R
Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
[No Abstract] [Full Text] [Related]
15. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
16. Biotech patents: the world is your oyster--or mouse--or (you name it).
Alix JE
Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
[TBL] [Abstract][Full Text] [Related]
17. Who deserves the patent pot of gold?: an inquiry into the proper inventorship of patient-based discoveries.
Ho CM
DePaul J Health Care Law; 2004; 7(2):185-243. PubMed ID: 15675072
[No Abstract] [Full Text] [Related]
18. Reexamining the research exemption.
Flores MA; Campbell C
Nat Biotechnol; 2005 Jun; 23(6):659-61. PubMed ID: 15940230
[No Abstract] [Full Text] [Related]
19. Locating gene patents within the patent system.
Rai AK
Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
[No Abstract] [Full Text] [Related]
20. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
